Kimura disease (KD) is a chronic inflammatory disorder with unknown etiology, most commonly manifesting as painless unilateral cervical lymphadenopathy or subcutaneous masses in the head or neck region. Kimura disease is an unusual vascular tumor that typically occurs at 20 to 30 years of age, more commonly in women. There has been no documented case of malignant transformation; however, recurrence rates after excision may be as high as 25%. Surgery and medical therapy are useful for treatment. We present a 28-year-old man developed a unilateral cervical mass associated with KD. We made a complete excisional resection of the mass. We could not see any evidence of relapsing and decided that proper surgical resection of the lesion can be a treatment for KD. Because the disease can be seen with nephritic syndrome and has different treatment options, the otolaryngology specialist should consider KD in patients with neck mass and eosinophilia.
We conducted a study to evaluate the effectiveness of muscle-pedicle hyoid bone flaps in the repair and reconstruction of the larynx and trachea in 23 patients who had undergone extended partial laryngectomy. Of this group, 17 patients had undergone surgery to correct laryngotracheal stenosis and 6 to remove laryngeal carcinoma. Intervention resulted in successful decannulation in 20 of the 23 patients (87.0%). Of the 3 patients who did not experience a successful outcome initially, 2 were successfully decannulated following a second intervention; the other patient required a total laryngectomy because of cancer recurrence. In light of our follow-up results, we conclude that hyoid bone appears to be an effective autograft in such cases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.